McNeil Consumer Healthcare has added five product lots to its January product recall. The Jan. 15 recall was separate from McNeil’s voluntary recall of children’s liquid medicines in May because of manufacturing and quality standards issues. Added to the January recall are four product lots of Benadryl Allergy Ultratab tablets and one product lot of extra strength Tylenol rapid release gels.

Company officials said the products were “inadvertently omitted” from the initial recall action. McNeil of Fort Washington, Pa., a division of Johnson & Johnson (NYSE:JNJ), has informed the Food and Drug Administration of the omission and the company’s decision to add the product lots to the recall list.

The January recall was initiated as a result of consumer complaints of a musty or moldy odor that has since been linked to the presence of trace amounts of a chemical called 2,4,6-tribromoanisole or TBA. McNeil determined that the source of TBA was the result of a breakdown of a chemical that is applied to wood used to build wooden pallets that transport and store product packaging materials.

The company said the risk of serious adverse medical events in people who have used the products is remote.

Additional information about the recalls including a list of all products that are part of the action is available at www.mcneilproductrecall.com. Bizjournal.